NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









NIMA Partners

NIMA Partners

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://nimanow.com/

Last Round

Corporate Funding

Apr 4, 2025

Total Funding Raised

$13.2M

Company Overview

NIMA Partners, Inc. is a health technology company that develops and sells a portable gluten detection sensor and related capsules for individuals with celiac disease and gluten intolerance.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, D2C Brands, Sensors

Business Model

B2C

Customer Profile

Usage-Based SaaS, Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

gluten detectorportable gluten sensorceliac diseasefood allergen testerconsumer health techgluten sensitivityfood testing systemantibody-based immunoassaydirect-to-consumerD2Crazor and blades modelconsumables modelHealth IoTcompanion mobile app

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NIMA Partners Comparables

Compare NIMA Partners with similar companies based on industry and business-model similarity.

NIMA Partners comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Allergy Amulet
85%
LEO Verification Systems
84%
EW Group
71%

NIMA Partners Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingApr 4, 2025
Series AMay 19, 2016

Key People

Founding team and executive leadership

Mike Glick

Chief Executive Officer

Executive Team

NIMA Partners Investors

Notable investors and investment history

NIMA Partners investors
InvestorRounds
Uncork CapitalSeed, Series A
RA Capital ManagementCorporate Funding
NIH RADxGrant
Upfront VenturesSeed, Series A
Lemnos LabsSeed, Series A
Foundry GroupSeries A
SK VenturesSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 25, 2026

    Grew 133% QoQ, from 3 to 7 employees.

  • Jan 24, 2026

    Grew 100% QoQ from 3 to 6 employees.

NIMA Partners Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NIMA Partners Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NIMA Partners's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range8
Year Founded2013
Last FundingApr 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.